675 N St Clair St, Chicago, Illinois, 60611
675 N St Clair St, Chicago, Illinois, 60611 - Suite 18-250
676 N St Clair St, Chicago, Illinois, 60611
676 N St Clair St, Chicago, Illinois, 60611 - Suite 600
Join us on September 20 in Columbus, OH! Register today to attend this conference to meet top sarcoidosis doctors, network with other patients, and learn more about sarcoidosis and FSR. Click here to learn more!
The purpose of this study is to determine whether ARA 290, a new class of compound, is effective in the treatment of the neuropathic symptoms of sarcoidosis. Brief interaction of ARA 290 with the innate repair receptor results in anti-apoptotic and anti-inflammatory activities in myriad of cells, tissues and organs throughout the body to activate repair mechanisms and accelerate healing, including the nerve damage that can be associated with sarcoidosis. Join this study!
The primary purpose of this study is to investigate the efficacy and safety of oral antimycobacterial therapy in patients with confirmed progressive pulmonary sarcoidosis. We suspect that the CLEAR regimen will improve the absolute FVC percent predicted in chronic pulmonary sarcoidosis participants. Join this study!
Join the FSR Patient Registry today! Be part of the change.